Oppenheimer Justin Robert 4

What Happened

• Justin Robert Oppenheimer, COO & National Group President of Surgery Partners, received a grant of 42,523 restricted stock awards (RSAs) on March 5, 2026. The award is reported at $14.11 per share for a total reported value of approximately $600,000. This was an award/acquisition (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-05; reported filing date: 2026-03-09 (timely reporting).
• Price/value: $14.11 per share; total value ≈ $600,000.
• Shares involved: 42,523 RSAs granted.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: RSAs vest in three equal annual installments beginning on the first anniversary of the grant (i.e., one-third vests each year).
• Transaction type: Award (A) — restricted stock granted, not an immediate sale; no 10b5-1 plan or tax-withholding note disclosed in the provided details.

Context

• RSAs are restricted shares that generally cannot be sold until they vest; this award represents a time-vesting compensation grant rather than a market purchase. Such grants are common as executive compensation and indicate future ownership potential if vesting conditions are met, but do not necessarily signal immediate insider market sentiment.